Last reviewed · How we verify
NCT04322201: COPPTRIAHL
Continuous Passive Paracentesis for Intra-abdominal Hypertension
NA trial testing continuous drainage of ascitic fluid using an intra-abdominal double lumen central venous catheter in Ascites Hepatic in 60 participants. Status unknown.
30 November 2021
Quick facts
| Lead sponsor | Centro Hospitalar de Lisboa Central |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 2 November 2019 |
| Primary completion | 30 November 2021 |
| Estimated completion | 31 May 2022 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- continuous drainage of ascitic fluid using an intra-abdominal double lumen central venous catheter
- Ultrasound-guided intermittent large-volume paracentesis
Conditions studied
- Ascites Hepatic — all drugs for Ascites Hepatic →
- Cirrhosis, Liver — all drugs for Cirrhosis, Liver →
- Hypertension, Intraabdominal — all drugs for Hypertension, Intraabdominal →
- Critical Illness — all drugs for Critical Illness →
Sponsor
Centro Hospitalar de Lisboa Central
Who can join
Adults 18 to 75, any sex, with Ascites Hepatic or Cirrhosis, Liver. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Liver cirrhosis patients in Intensive Care present intra-abdominal hypertension and this is an independent risk factor for increased organ disfunction and mortality. Patients will be randomized into intermittent or continuous passive paracentesis and the clinical results of these two strategies for preventing and treating intra-abdominal hypertension will compared.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Intra-abdominal hypertension and abdominal compartment syndrome in the critically ill liver cirrhotic patient-prevalence and clinical outcomes. A multicentric retrospective cohort study in intensive care.
Pereira R, Buglevski M, Perdigoto R, Marcelino P, et al · · 2021 · cited 17× · PMID 33984016 · DOI 10.1371/journal.pone.0251498 -
Continuous passive paracentesis versus large-volume paracentesis in the prevention and treatment of intra-abdominal hypertension in the critically ill cirrhotic patient with ascites (COPPTRIAHL): study protocol for a randomized controlled trial.
Pereira RA, Virella D, Perdigoto R, Marcelino P, et al · · 2023 · cited 1× · PMID 37582719 · DOI 10.1186/s13063-023-07541-4 -
ESICM LIVES 2025
· 2025
Verify or expand the search:
- PubMed search for NCT04322201
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ascites Hepatic
Currently open trials in the same condition.
- NCT06576934 — Early TIPS in Patients With Liver Cirrhosis and Ascites · NA · recruiting
- NCT06669806 — Effectiveness and Safety of TIPS Stent Graft in the Treatment of Cirrhosis and Complications of Portal Hypertension · NA · recruiting
- NCT07349654 — Underdilated-stent Technique Improves Post-TIPS Encephalopathy · NA · recruiting
- NCT06224023 — Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure · recruiting
- NCT05999773 — SGLT-2 Inhibitors in the Treatment of Ascites · recruiting
Other Centro Hospitalar de Lisboa Central trials
Trials by the same sponsor.
- NCT07483424 — Determination of Clinical Phenotypes of Intrauterine Growth Restriction in Term Infants Based on Body Composition · enrolling by invitation
- NCT06830226 — Domperidone on the Composition of Preterm Breastmilk Using a Human Milk Mid-infrared Spectroscopy Analyzer · enrolling by invitation
- NCT06839443 — Deep Learning in the Detection and Prediction of Hydroxychloroquine Maculopathy · recruiting
- NCT06094309 — Effectiveness of Botulinum Toxin in Freezing of Gate in Parkinson's Disease Walking in Parkinson's Disease. · NA · unknown
- NCT06044480 — Effect of Dexamethason on Postimplantation Syndrome After EVAR · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04322201 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centro Hospitalar de Lisboa Central
- Last refreshed: 26 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04322201.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing